Repligen on Bioeconhttps://en.bioecon.ru/companies/repligen/Recent content in Repligen on BioeconHugoen-USSat, 25 Jul 2026 22:12:11 +0700Downstream Purification & Bioseparationhttps://en.bioecon.ru/technology/downstream-purification-bioseparation/Fri, 19 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/downstream-purification-bioseparation/Downstream purification converts crude bioreactor harvests into clinical-grade drug substance — chromatography (Protein A, IEX, HIC), tangential-flow filtration, and viral clearance together account for >50% of biomanufacturing CAPEX. The global DSP market exceeds $5B and grows at >8% CAGR driven by mAb and cell-gene therapy demand.